黄仕龙;徐飞;董永辉;郭风劲;陈安民;许涛;

• 1:华中科技大学同济医学院附属同济医院骨外科
• 2:华中科技大学同济医学院附属同济医院康复科

摘要(Abstract)：

[目的]体外观察TZDs类药物对小鼠原代骨髓细胞向成骨细胞和破骨细胞分化的影响,探讨其对糖尿病患者骨骼代谢的影响和作用机制。[方法]无菌条件下从小鼠股骨分离获取骨髓细胞,贴壁细胞进行成骨细胞生成实验研究,悬浮细胞进行破骨细胞生成实验研究。随后在1、2、5μmol/L罗格列酮干预下诱导成骨细胞分化培养3周,进行Von Kossa染色观察成骨细胞矿化结节,并测定成骨细胞标记物ALP活性、BMP-2及TGF-β分泌的影响;观察罗格列酮对破骨细胞形成和成熟的影响及标志性基因表达。[结果]1、2、5μmol/L罗格列酮干预组与对照组相比,成骨细胞的钙结节形成比例显著降低(P<0.05),ALP、BMP-2、TGF-β水平呈剂量依赖性地下降(均P<0.05);同时剂量依赖性促进c-fos和RANK基因的表达,破骨细胞生成实验显示罗格列酮促进破骨细胞分化发育和成熟。[结论]罗格列酮可剂量依赖性地抑制骨髓细胞向成骨细胞分化,促进向破骨细胞分化。有助于理解Ⅱ型糖尿病患者在应用TZDs骨丢失的原因。

关键词(KeyWords)： 罗格列酮;成骨细胞;破骨细胞;糖尿病骨代谢

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(编号:81070691)

作者(Author): 黄仕龙;徐飞;董永辉;郭风劲;陈安民;许涛;

Email:

DOI:

参考文献(References)：

• [1]Rzonca SO,Suva LJ,Gaddy D,et al.Bone is a target for the antidia-betic compound rosiglitazone[J].Endocrinology,2004,1:401-406.
• [2]Grey A,Bolland M,Gamble G,et al.The peroxisome proliferators-activated receptor-gamma agonist rosiglitazone decreases bone forma-tion and bone mineral density in healthy postmenopansal women:arandomized,controlled trial[J].J Clin Endocrinol Metab,2007,92:1305-1310.
• [3]Lazarenko OP,Rzonca SO,Hogue WR,et al.Rosiglitazone induces de-creases in bone mass and strength that are reminiscent of aged bone[J].Endocrinology,2007,6:2669-2680.
• [4]Huang S,Kaw M,Harris MT,et al.Decreased osteoclastogenesis andhigh bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1[J].Bone,2010,4:1138-1145.
• [5]Boyce BF,Xing L.Functions of RANKL/RANK/OPG in bone mod-eling and remodeling[J].Arch Biochem Biophys,2008,473:139-146.
• [6]Wan Y,Chong LW,Evans RM.PPAR-gamma regulates osteoclasto-genesis in mice[J].Nat Med,2007,13:1496-1503.
• [7]Seale P,Bjork B,Yang WL,et al.PRDM16 controls a brown fat/skeletal muscle switch[J].Nature,2008,454:961-997.
• [8]Rosen ED,Spiegelman BM.PPARgamma:a nuclear regulator of me-tabolism,differentiation,and cell growth[J].J Biol Chem,2001,276:37731-37734.
• [9]Lecka-Czernik B,Moerman EJ,Grant DF,et al.Divergent effects ofselective peroxisome proliferator-activated receptor-gamma 2 lig-ands on adipocyte versus osteoblast differentiation[J].Endocrinology,2002,143:2376-2384.
• [10]Silva MJ,Brodt MD,Abu-Amer Y.Impaired marrow osteogenesis isassociated with reduced endocortical bone formation but does not im-pair periosteal boone formation in long bones of SAMP6 mice[J].JBone Miner Res,2005,20:419-427.